BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 29806502)

  • 41. Impaired brain metabolism and neurocognitive function in childhood leukemia survivors despite complete hormone supplementation in adulthood.
    Follin C; Erfurth EM; Johansson A; Lätt J; Sundgren PC; Österberg K; Spulber G; Mannfolk P; Björkman-Burtscher IM
    Psychoneuroendocrinology; 2016 Nov; 73():157-165. PubMed ID: 27498291
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exploring primary breast cancer survivors' self-management of sustained cancer-related cognitive impairment in the workplace.
    Chapman B; Derakshan N; Grunfeld EA
    Psychooncology; 2022 Apr; 31(4):606-613. PubMed ID: 34699652
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Experiences of cognitive training on primary breast cancer survivor's cognitive impairments at work: A longitudinal qualitative study.
    Chapman B; Derakshan N; Grunfeld EA
    Br J Health Psychol; 2023 Feb; 28(1):252-270. PubMed ID: 36086995
    [TBL] [Abstract][Full Text] [Related]  

  • 44. "I couldn't connect the wires in my brain." Young adult cancer survivors' experience with cognitive functioning.
    Tometich DB; Welniak T; Gudenkauf L; Maconi ML; Fulton HJ; Martinez Tyson D; Zambrano K; Hasan S; Rodriguez Y; Bryant C; Li X; Reed DR; Oswald LB; Galligan A; Small BJ; Jim HSL
    Psychooncology; 2024 Mar; 33(3):e6309. PubMed ID: 38420860
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Associations of plasma brain-derived neurotrophic factor (BDNF) and Val66Met polymorphism (rs6265) with long-term cancer-related cognitive impairment in survivors of breast cancer.
    Yap NY; Tan NYT; Tan CJ; Loh KW; Ng RCH; Ho HK; Chan A
    Breast Cancer Res Treat; 2020 Oct; 183(3):683-696. PubMed ID: 32696315
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Probiotic supplement attenuates chemotherapy-related cognitive impairment in patients with breast cancer: a randomised, double-blind, and placebo-controlled trial.
    Juan Z; Chen J; Ding B; Yongping L; Liu K; Wang L; Le Y; Liao Q; Shi J; Huang J; Wu Y; Ma D; Ouyang W; Tong J
    Eur J Cancer; 2022 Jan; 161():10-22. PubMed ID: 34896904
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Brain cortical structural differences between non-central nervous system cancer patients treated with and without chemotherapy compared to non-cancer controls: a cross-sectional pilot MRI study using clinically-indicated scans.
    Shiroishi MS; Gupta V; Bigjahan B; Cen SY; Rashid F; Hwang DH; Lerner A; Boyko OB; Liu CJ; Law M; Thompson PM; Jahanshad N
    Proc SPIE Int Soc Opt Eng; 2017 Oct; 10572():. PubMed ID: 30034079
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanisms and Treatment for Cancer- and Chemotherapy-Related Cognitive Impairment in Survivors of Non-CNS Malignancies.
    Chung NC; Walker AK; Dhillon HM; Vardy JL
    Oncology (Williston Park); 2018 Dec; 32(12):591-8. PubMed ID: 30632128
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictors of cognitive impairment in patients undergoing ileostomy for colorectal cancer: a retrospective analysis.
    Xu J; Yang Y; Hu D
    PeerJ; 2023; 11():e15405. PubMed ID: 37304889
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recovery from chemotherapy-induced white matter changes in young breast cancer survivors?
    Billiet T; Emsell L; Vandenbulcke M; Peeters R; Christiaens D; Leemans A; Van Hecke W; Smeets A; Amant F; Sunaert S; Deprez S
    Brain Imaging Behav; 2018 Feb; 12(1):64-77. PubMed ID: 28102529
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Preliminary Study on the Relationship between Serum Heparan Sulfate and Cancer-Related Cognitive Impairment: The Moderating Role of Oxidative Stress in Patients with Colorectal Cancer.
    Wang D; Wang T; Zhu M; Sun J; Zhou Z; Chen J; Teng L
    Curr Oncol; 2022 Apr; 29(4):2681-2694. PubMed ID: 35448193
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cancer-related cognitive impairment in children.
    Hutchinson AD; Pfeiffer SM; Wilson C
    Curr Opin Support Palliat Care; 2017 Mar; 11(1):70-75. PubMed ID: 28009650
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Developmental Trajectory of Cancer-Related Cognitive Impairment in Breast Cancer Patients: A Systematic Review of Longitudinal Neuroimaging Studies.
    Sousa H; Almeida S; Bessa J; Pereira MG
    Neuropsychol Rev; 2020 Sep; 30(3):287-309. PubMed ID: 32607817
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neurocircuitry of acupuncture effect on cognitive improvement in patients with mild cognitive impairment using magnetic resonance imaging: a study protocol for a randomized controlled trial.
    Suh HW; Kim J; Kwon O; Cho SH; Kim JW; Kwak HY; Kim Y; Lee KM; Chung SY; Lee JH
    Trials; 2019 May; 20(1):310. PubMed ID: 31146774
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemotherapy-induced cognitive impairment in breast cancer survivors: A systematic review of studies from 2000 to 2021.
    Amani O; Mazaheri MA; Moghani MM; Zarani F; Choolabi RH
    Cancer Rep (Hoboken); 2024 Feb; 7(2):e1989. PubMed ID: 38351543
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of exercise on cancer-related cognitive impairment in breast cancer survivors: a scoping review.
    Jesús OJ; Luis CP; Matilde MF
    Breast Cancer; 2023 Nov; 30(6):885-909. PubMed ID: 37480454
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changes in brain white matter integrity after systemic treatment for breast cancer: a prospective longitudinal study.
    Menning S; de Ruiter MB; Veltman DJ; Boogerd W; Oldenburg HSA; Reneman L; Schagen SB
    Brain Imaging Behav; 2018 Apr; 12(2):324-334. PubMed ID: 28290072
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Subtle hippocampal deformities in breast cancer survivors with reduced episodic memory and self-reported cognitive concerns.
    Apple AC; Ryals AJ; Alpert KI; Wagner LI; Shih PA; Dokucu M; Cella D; Penedo FJ; Voss JL; Wang L
    Neuroimage Clin; 2017; 14():685-691. PubMed ID: 28377882
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Longitudinal assessment of chemotherapy-induced brain connectivity changes in cerebral white matter and its correlation with cognitive functioning using the GQI.
    Chen VC; Chuang W; Tsai YH; McIntyre RS; Weng JC
    Front Neurol; 2024; 15():1332984. PubMed ID: 38385045
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cognitive impairment in gynecologic cancers: a systematic review of current approaches to diagnosis and treatment.
    Craig CD; Monk BJ; Farley JH; Chase DM
    Support Care Cancer; 2014 Jan; 22(1):279-87. PubMed ID: 24212261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.